(TSU) Trisura - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA89679A2092

TSU: Insurance, Bonds, Reinsurance, Surety, Contracts

Trisura Group Ltd. is a specialty insurance company with a focused portfolio across surety, risk solutions, corporate insurance, and reinsurance. Operating primarily in Canada and the United States, the company has built a niche in serving construction, manufacturing, and service contractors through its contract surety bonds, which include performance and labor/material payment bonds. These bonds are critical for ensuring project completion and payment security in high-stakes industries.

Through its U.S. and Canadian segments, Trisura offers a range of risk solutions, fronting services, and specialized insurance products. The company’s commercial surety bonds cater to federal and state courts, government entities, financial institutions, and private corporations, addressing the need for security in legal and financial transactions. This diversification allows Trisura to maintain a balanced risk profile while capitalizing on growth opportunities in both mature and specialized insurance markets.

Founded in 2017 and headquartered in Toronto, Trisura has quickly established itself as a player in the North American specialty insurance space. With a market capitalization of CAD 1.72 billion, the company trades at a P/E ratio of 14.77, with a forward P/E of 11.99, suggesting investor expectations of future earnings growth. Its price-to-book ratio of 2.19 reflects the market’s valuation of its balance sheet strength, while the price-to-sales ratio of 0.54 indicates a potential undervaluation relative to its revenue generation.

Trisura’s focus on underwriting discipline and risk management has positioned it well to navigate the complexities of the specialty insurance market. Its ability to provide tailored solutions for contractors, corporations, and government entities underscores its strategic relevance in a sector where trust, reliability, and financial stability are paramount. For investors, Trisura’s combination of a diversified product portfolio, geographic reach, and financial stability makes it a compelling option in the property and casualty insurance space.

Additional Sources for TSU Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

TSU Stock Overview

Market Cap in USD 1,315m
Sector Financial Services
Industry Insurance - Specialty
GiC Sub-Industry Property & Casualty Insurance
IPO / Inception

TSU Stock Ratings

Growth Rating 37.9
Fundamental 59.0
Dividend Rating 0.0
Rel. Strength -26.6
Analysts -
Fair Price Momentum 36.58 CAD
Fair Price DCF 47.13 CAD

TSU Dividends

No Dividends Paid

TSU Growth Ratios

Growth Correlation 3m 19.1%
Growth Correlation 12m -80.2%
Growth Correlation 5y 39.5%
CAGR 5y 30.20%
CAGR/Max DD 5y 0.75
Sharpe Ratio 12m -0.93
Alpha -19.08
Beta 0.579
Volatility 34.73%
Current Volume 118.4k
Average Volume 20d 94.7k
What is the price of TSU stocks?
As of May 01, 2025, the stock is trading at CAD 37.85 with a total of 118,352 shares traded.
Over the past week, the price has changed by +6.05%, over one month by +13.22%, over three months by +14.25% and over the past year by -9.99%.
Is Trisura a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Trisura (TO:TSU) is currently (May 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 58.97 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TSU as of May 2025 is 36.58. This means that TSU is currently overvalued and has a potential downside of -3.36%.
Is TSU a buy, sell or hold?
Trisura has no consensus analysts rating.
What are the forecast for TSU stock price target?
According to ValueRays Forecast Model, TSU Trisura will be worth about 40.8 in May 2026. The stock is currently trading at 37.85. This means that the stock has a potential upside of +7.9%.
Issuer Forecast Upside
Wallstreet Target Price 51.6 36.4%
Analysts Target Price - -
ValueRay Target Price 40.8 7.9%